May 19, 2017 - By Hazel Jackson
The President of Allscripts Healthcare Solutions Inc and company’s insider Richard Poulton sold 25,000 shares of the corporation based on the average price of $12.1 per share. The shares are worth around $301,383 US Dollars. The trade was revealed in a filing submitted with the Security and Exchange Commission on May 18, 2017, which is available for free access here. Richard Poulton now owns 412,488 shares or 0.23% of Allscripts Healthcare Solutions Inc’s total market cap.
Among 6 analysts covering Sportsmans Warehouse (NASDAQ:SPWH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Sportsmans Warehouse had 11 analyst reports since August 28, 2015 according to SRatingsIntel. The stock has “Buy” rating by M Partners on Monday, May 23. Goldman Sachs maintained it with “Buy” rating and $16.50 target in Thursday, March 24 report. The rating was downgraded by PiperJaffray to “Neutral” on Friday, March 24. The stock has “Buy” rating by M Partners on Friday, November 20. On Friday, August 28 the stock rating was maintained by M Partners with “Buy”. The rating was reinitiated by Credit Suisse on Thursday, March 24 with “Outperform”. Goldman Sachs downgraded the shares of SPWH in report on Monday, March 27 to “Neutral” rating. On Friday, November 20 the stock rating was maintained by DA Davidson with “Buy”. Sterne Agee CRT maintained Sportsman’s Warehouse Holdings Inc (NASDAQ:SPWH) on Sunday, August 30 with “Buy” rating. The stock of Sportsman’s Warehouse Holdings Inc (NASDAQ:SPWH) has “Buy” rating given on Thursday, September 3 by DA Davidson. See Sportsman’s Warehouse Holdings Inc (NASDAQ:SPWH) latest ratings:
27/03/2017 Broker: Goldman Sachs Old Rating: Buy New Rating: Neutral Old Target: $8.50 New Target: $6.50 Downgrade
24/03/2017 Broker: PiperJaffray Old Rating: Overweight New Rating: Neutral Downgrade
Sportsman’s Warehouse Holdings, Inc
The stock decreased 2.47% or $0.12 during the last trading session, reaching $4.73. About shares traded. Sportsman’s Warehouse Holdings Inc (NASDAQ:SPWH) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.
The stock increased 1.11% or $0.13 during the last trading session, reaching $11.86. About shares traded. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.
Investors sentiment increased to 1.09 in Q4 2016. Its up 0.10, from 0.99 in 2016Q3. It is positive, as 32 investors sold Allscripts Healthcare Solutions Inc shares while 73 reduced holdings. 38 funds opened positions while 76 raised stakes. 178.73 million shares or 5.65% less from 189.44 million shares in 2016Q3 were reported. Alliancebernstein Limited Partnership holds 0% or 139,524 shares in its portfolio. Principal Group reported 737,261 shares. The Wisconsin-based Northwestern Mutual Wealth Management has invested 0% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Moreover, Continental Advsrs Ltd Liability Co has 0.2% invested in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) for 72,323 shares. Pnc Fin reported 0% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Moreover, Profund Advsrs Limited has 0.05% invested in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Blackrock Inv Mgmt Ltd Co owns 653,440 shares. Blackrock Advsrs Limited Liability Company reported 110,011 shares. Liberty Mutual Asset Management Incorporated invested in 0.03% or 76,634 shares. Convergence Invest Prtnrs Limited Liability accumulated 338,130 shares. Nomura Asset Communications Limited owns 1,300 shares. Sei Invs reported 0.02% stake. Hbk Investments L P invested 0.03% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Oregon Employees Retirement Fund has invested 0.01% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Blair William Il has invested 0% of its portfolio in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).
Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The company has market cap of $2.07 billion. The Firm operates through three divisions: Clinical and Financial Solutions, Population Health, and Netsmart. It currently has negative earnings. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Among 21 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 10 have Buy rating, 1 Sell and 10 Hold. Therefore 48% are positive. Allscripts-Misys Healthcare has $19.0 highest and $12 lowest target. $15.28’s average target is 28.84% above currents $11.86 stock price. Allscripts-Misys Healthcare had 32 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, August 5 by Topeka Capital Markets. The stock has “Neutral” rating by Dougherty & Company on Friday, December 2. JP Morgan reinitiated Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Friday, October 28 with “Overweight” rating. RBC Capital Markets maintained the stock with “Sector Perform” rating in Wednesday, August 5 report. JP Morgan initiated Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Tuesday, November 17 with “Overweight” rating. Raymond James downgraded the stock to “Mkt Perform” rating in Monday, January 4 report. The rating was initiated by Canaccord Genuity with “Buy” on Wednesday, September 16. RBC Capital Markets maintained it with “Outperform” rating and $17 target in Friday, February 19 report. Citigroup maintained the shares of MDRX in report on Friday, May 13 with “Neutral” rating. On Friday, October 16 the stock rating was reinitiated by Jefferies with “Buy”.
Since March 23, 2017, it had 0 insider buys, and 1 sale for $174,467 activity. Farley Brian also sold $174,467 worth of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Thursday, March 23.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.